We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Health Insurance Innovations (HIIQ) Q2 Earnings Preview
Read MoreHide Full Article
Health Insurance Innovations, Inc. is set to report second-quarter 2019 earnings on Aug 5, after market close. The company delivered positive surprise in three of the last four reported quarters.
Let’s see what’s in store for the company in the soon-to-be reported quarter.
Health Insurance Innovations’ second-quarter results are likely to benefit from its compelling portfolio of core products and individual and family plans along with life, critical illness, accidental death dental, vision and a range of other supplemental plans.
The strategy to focus on longer duration, higher lifetime value plans and e-commerce penetration and shift from lower cost and lower margin products should continue to benefit the company.
Better cross-sell experience is likely to aid premiums at agile.
Focus on the Life Insurance market and addition of compelling products to the portfolio should aid results.
Continued share buybacks should drive the bottom line.
The Department of Health and Human Services of the U.S. government implemented a rule on Oct 2, 2018 that changed the maximum duration of short-term medical policies to less than one year from the present duration of less than three months. Also, the rule allows more affordable health insurance options. The company expects to gain from favorable regulatory outcomes.
Increase in digital marketing investment at e-commerce channels is likely to escalate selling, general and administrative expenses.
The Zacks Consensus Estimate for earnings per share for the quarter to-be reported is pegged at 39 cents, implying a decrease of 36.1% from the year-ago reported figure.
The company estimates second-quarter revenues to represent 18% of 2019 revenues and 12% of adjusted earnings.
What Our Quantitative Model Predicts
Our proven model does not conclusively show that Health Insurance Innovations is likely to beat on earnings this reporting season. This is because a stock needs to have the right combination of a positive Earnings ESP and a favorable Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). But this is not the case here as you can see below.
Earnings ESP: Health Insurance Innovations has an Earnings ESP of -22.41%. This is because the Most Accurate Estimate of 30 cents is pegged lower than the Zacks Consensus Estimate of 39 cents. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Health Insurance Innovations, Inc. Price and EPS Surprise
Zacks Rank: Health Insurance Innovations sports a Zacks Rank #1.
We caution against Zacks Rank #4 (Sell) or 5 (Strong Sell) stocks going into an earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Some stocks from the insurance industry with the right combination of elements to surpass estimates this time around are as follows:
Voya Financial (VOYA - Free Report) has an Earnings ESP of +0.68% and a Zacks Rank of 3. The company is scheduled to release second-quarter earnings on Aug 6.
Alleghany has an Earnings ESP of +1.69% and a Zacks Rank of 3. The company is slated to announce second-quarter earnings on Aug 6.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
Health Insurance Innovations (HIIQ) Q2 Earnings Preview
Health Insurance Innovations, Inc. is set to report second-quarter 2019 earnings on Aug 5, after market close. The company delivered positive surprise in three of the last four reported quarters.
Let’s see what’s in store for the company in the soon-to-be reported quarter.
Health Insurance Innovations’ second-quarter results are likely to benefit from its compelling portfolio of core products and individual and family plans along with life, critical illness, accidental death dental, vision and a range of other supplemental plans.
The strategy to focus on longer duration, higher lifetime value plans and e-commerce penetration and shift from lower cost and lower margin products should continue to benefit the company.
Better cross-sell experience is likely to aid premiums at agile.
Focus on the Life Insurance market and addition of compelling products to the portfolio should aid results.
Continued share buybacks should drive the bottom line.
The Department of Health and Human Services of the U.S. government implemented a rule on Oct 2, 2018 that changed the maximum duration of short-term medical policies to less than one year from the present duration of less than three months. Also, the rule allows more affordable health insurance options. The company expects to gain from favorable regulatory outcomes.
Increase in digital marketing investment at e-commerce channels is likely to escalate selling, general and administrative expenses.
The Zacks Consensus Estimate for earnings per share for the quarter to-be reported is pegged at 39 cents, implying a decrease of 36.1% from the year-ago reported figure.
The company estimates second-quarter revenues to represent 18% of 2019 revenues and 12% of adjusted earnings.
What Our Quantitative Model Predicts
Our proven model does not conclusively show that Health Insurance Innovations is likely to beat on earnings this reporting season. This is because a stock needs to have the right combination of a positive Earnings ESP and a favorable Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). But this is not the case here as you can see below.
Earnings ESP: Health Insurance Innovations has an Earnings ESP of -22.41%. This is because the Most Accurate Estimate of 30 cents is pegged lower than the Zacks Consensus Estimate of 39 cents. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Health Insurance Innovations, Inc. Price and EPS Surprise
Health Insurance Innovations, Inc. price-eps-surprise | Health Insurance Innovations, Inc. Quote
Zacks Rank: Health Insurance Innovations sports a Zacks Rank #1.
We caution against Zacks Rank #4 (Sell) or 5 (Strong Sell) stocks going into an earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Some stocks from the insurance industry with the right combination of elements to surpass estimates this time around are as follows:
American Financial Group (AFG - Free Report) is set to report second-quarter earnings on Aug 6. The company has an Earnings ESP of +0.50% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Voya Financial (VOYA - Free Report) has an Earnings ESP of +0.68% and a Zacks Rank of 3. The company is scheduled to release second-quarter earnings on Aug 6.
Alleghany has an Earnings ESP of +1.69% and a Zacks Rank of 3. The company is slated to announce second-quarter earnings on Aug 6.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>